Tempus Unveils New Whole-Genome Sequencing Assay
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
The whole-genome sequencing assay enhances precision medicine by identifying relevant genetic alterations in hematological malignancies.
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
The platform offers a flexible modular hematology solution that is fully scalable with myriad configurations for mid to large-scale labs.
The Sysmex XN Blood Bank mode is intended for use in blood processing centers for QC release testing of post-processed components.
Roche will continue to offer Sysmex' hematology products, complementing their total lab solutions portfolio, the companies say.
Nova Biomedical’s Stat Profile Prime Plus critical care analyzer now has the ability to calculate and report estimated plasma volume.
HemoSonics announced its Quantra Hemostasis System received an Innovative Technology contract award from Vizient.
Researchers have developed an electronic device for continuously monitoring the health of transplanted organs in real-time.